COASY Antibody

What is COASY and what are its primary functions relevant to antibody-based research?

COASY (Coenzyme A synthase) is a bifunctional enzyme that catalyzes the fourth and fifth sequential steps of the CoA biosynthetic pathway. This 62 kDa protein (564 amino acids) plays a crucial role in coenzyme A biosynthesis and lipid metabolism . The phosphopantetheine adenylyltransferase activity is coded by the coaD domain, which is essential for cellular energy metabolism . COASY is involved in various physiological processes, making it a target for research in metabolic disorders, neurodegenerative diseases, and cancer . When designing antibody-based experiments, researchers should consider that COASY is predominantly expressed in metabolically active tissues and often localizes to mitochondria, which can influence experimental design for subcellular localization studies.

What are the optimal applications and dilutions for COASY antibody in standard laboratory techniques?

COASY antibodies have been validated in multiple applications with specific recommended dilutions for optimal results:

It is strongly recommended that researchers titrate the antibody in each testing system to obtain optimal results, as the appropriate dilution may be sample-dependent . For immunohistochemistry applications, antigen retrieval with TE buffer pH 9.0 is suggested, though citrate buffer pH 6.0 may alternatively be used . In published research, COASY antibodies have been most extensively validated for Western blot applications.

What specimen types have been successfully used with COASY antibodies?

COASY antibodies have demonstrated reactivity with human, mouse, and rat samples . In human specimens, successful detection has been reported in:

• Cell lines: HeLa cells, HEK-293 cells (for Western blot and immunofluorescence)

• Tissue samples: Human colon cancer tissue (for immunohistochemistry)

• Patient-derived fibroblasts (for studies of COASY-associated diseases)

When working with new specimen types, researchers should perform validation experiments with appropriate positive and negative controls. The antibody's ability to detect COASY in different sample types may depend on protein abundance, post-translational modifications, and tissue-specific expression patterns.

What are the proper storage and handling conditions for maintaining COASY antibody activity?

For optimal stability and performance, COASY antibodies should be stored at -20°C, where they remain stable for one year after shipment . The storage buffer typically consists of PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 .

Importantly, aliquoting is unnecessary for -20°C storage, which simplifies laboratory handling procedures. Some preparations, particularly those in 20μl sizes, may contain 0.1% BSA as a stabilizer . When working with the antibody, minimize freeze-thaw cycles to preserve activity, and keep the antibody on ice during experimental procedures. Always centrifuge the vial briefly before opening to ensure all liquid is at the bottom of the tube.

How does COASY contribute to radiation resistance in cancer, and what experimental approaches best elucidate this mechanism?

COASY has been identified as a novel biomarker whose mRNA expression is consistently elevated in radioresistant human rectal cancers . Research has demonstrated that COASY protein directly interacts with the PI3K regulatory subunit PI3K-P85α, which increases AKT and mTOR phosphorylation, enhancing cell survival during radiation treatment .

For investigating COASY's role in radiation resistance, researchers should consider:

• Genetic manipulation approaches: Both overexpression and knockdown models yield radioresistant and sensitive phenotypes, respectively, in vitro and in vivo. COASY-knockdown xenografts show delayed tumor growth, decreased proliferation, and increased apoptosis when subjected to radiation .

• Experimental design for radiation studies: Clonogenic survival assays using rectal cancer cell lines (such as RKO and HRT-18) with knockdown or overexpression of COASY provide quantitative assessment of radiation sensitivity .

• Mechanistic investigation: Co-immunoprecipitation experiments can confirm direct interaction between COASY and PI3K-P85α. Subsequent phosphorylation analysis of AKT and mTOR via Western blotting helps establish the downstream signaling pathway activated by COASY .

• In vivo validation: Xenograft models using COASY-manipulated cancer cells can validate in vitro findings and provide insights into tumor response to radiation therapy.

This research suggests that targeting COASY could potentially sensitize radioresistant tumors to radiation therapy, highlighting its importance as both a predictive biomarker and therapeutic target.

What methodological considerations are crucial when studying COASY genetic variants and their associated diseases?

When investigating COASY genetic variants and their relationship to disease states, researchers should implement a multi-faceted methodological approach:

• Genetic sequencing and variant classification: All variants should be numbered according to established reference sequences (e.g., NM_025233.7) . Novel variants should be assessed using prediction tools such as CADD, SIFT, Polyphen-2, and MutationTaster, and classified according to ACMG guidelines .

• Structural and functional domain analysis: Determine if identified variants affect critical domains of COASY, such as the DPCK domain which is essential for enzymatic function . The location of variants within specific domains can provide insights into potential functional consequences.

• Fibroblast transcriptomic profiling: This approach can reveal dysregulated expression in genes associated with mitochondrial respiration, responses to oxidative stress, transmembrane transport, cellular signaling pathways, and protein processing .

• Bioenergetic analysis: Assessment of mitochondrial oxygen consumption in COASY-variant fibroblasts can identify functional consequences of genetic alterations .

• CoA level quantification: Despite comparable total CoA levels between patient and control cells, the amounts of mitochondrial 4′-phosphopantetheinylated proteins may be significantly reduced in COASY patients, requiring specific analytical techniques to detect these subtle changes .

• Protein expression analysis: Immunoblotting using specific antibodies (e.g., anti-COASY Thermofisher PA528696) alongside markers for related pathways (NDUFAB1, ALDH1L2) can help establish protein expression changes resulting from genetic variants .

These approaches collectively provide a comprehensive understanding of how COASY variants contribute to disease pathophysiology, particularly in conditions like CoPAN (COASY Protein-Associated Neurodegeneration) and other COASY-associated disorders.

What are the critical factors for successful immunohistochemical detection of COASY in tissue samples?

Successful immunohistochemical detection of COASY in tissue samples requires careful attention to several methodological factors:

• Antigen retrieval method selection: For COASY detection in paraffin-embedded sections, antigen unmasking solution (such as Vector laboratories Cat# H300) is recommended . Alternatively, researchers should consider using TE buffer pH 9.0 or citrate buffer pH 6.0 for optimal antigen retrieval .

• Antibody selection and dilution: Anti-COASY antibodies from different sources require specific dilutions for IHC. For example, Abcam's antibody (Cat# ab227272) is typically used at 1:500 dilution , while Proteintech's 12991-1-AP is recommended at 1:100 for human colon cancer tissue or 1:20-1:200 depending on sample type .

• Tissue type considerations: COASY has been successfully detected in human colon cancer tissue , but expression levels may vary across different tissue types. Researchers should:

  • Include positive controls with known COASY expression

  • Perform parallel Western blot analysis to confirm antibody specificity

  • Consider tissue-specific optimization of the IHC protocol

• Signal development and visualization: For COASY, standard DAB (3,3'-diaminobenzidine) detection is typically effective, but for tissues with high background or low expression, signal amplification methods may improve sensitivity.

• Validation of specificity: Confirmatory approaches such as using different antibodies targeting distinct epitopes of COASY or performing IHC on tissues with genetic knockdown of COASY help ensure signal specificity.

The immunohistochemical analysis should be performed under strict pathological supervision with appropriate IRB approval when using human tissue samples .

How can researchers effectively design and validate COASY knockdown or overexpression models?

Creating reliable COASY manipulation models requires systematic approach to ensure proper phenotype development and validation:

• Knockdown strategies:

  • Lentiviral constructs containing different shRNAs targeting COASY mRNA have proven effective (using at least two different shRNA sequences to control for off-target effects)

  • Selection with puromycin in the culture media establishes stable knockdown cell lines

  • Validation through qRT-PCR and Western blot is essential to confirm reduced COASY expression

• Overexpression approaches:

  • Transfection with expression vectors (such as pCMV3-COASY-GFP) with appropriate empty vector controls (pCMV3-GFP)

  • Culture under hygromycin selection pressure to establish stable overexpression lines

  • The GFP tag facilitates visualization and confirmation of expression, but researchers should verify that the tag doesn't interfere with COASY function

• Validation of functional consequences:

  • Clonogenic survival assays provide quantitative assessment of phenotypic changes

  • Assessment of CoA biosynthetic pathway activity confirms functional impact

  • Analysis of downstream signaling (PI3K/AKT/mTOR) validates mechanistic effects

• In vivo validation:

  • Xenograft models using manipulated cell lines can confirm in vitro findings

  • Analysis of tumor growth, proliferation markers, and apoptosis provides comprehensive phenotypic assessment

These models are particularly valuable for investigating COASY's role in radiation resistance, metabolic disorders, and neurodegenerative diseases, providing platforms for both mechanistic studies and therapeutic development.

What approaches should researchers use to investigate COASY protein-protein interactions?

Investigation of COASY protein-protein interactions requires multiple complementary techniques to establish biological relevance:

• Co-immunoprecipitation (Co-IP):

  • The COASY antibody (12991-1-AP) has been validated for immunoprecipitation using 4μg antibody with 3200μg HeLa cell lysate

  • This technique has successfully demonstrated direct interaction between COASY and PI3K-P85α

  • Both forward and reverse Co-IP approaches should be employed for confirmation

  • Controls should include IgG of the same species as the primary antibody

• Proximity ligation assay (PLA):

  • This technique can visualize protein-protein interactions in situ within cells or tissues

  • Requires two primary antibodies from different species targeting the two proteins of interest

  • Particularly valuable for confirming interactions in their native cellular context

• Mass spectrometry-based interactome analysis:

  • Pull-down of COASY followed by mass spectrometry identifies interaction partners

  • SILAC (Stable Isotope Labeling with Amino acids in Cell culture) approaches can quantify interaction strengths

  • Bioinformatic analysis of identified partners can reveal functional interaction networks

• Functional validation of interactions:

  • Mutational analysis of COASY's interaction domains can establish specificity

  • Downstream signaling analysis (e.g., AKT/mTOR phosphorylation status following COASY-PI3K interaction)

  • Cellular phenotype assessment after disrupting specific interactions

• Structural biology approaches:

  • In silico modeling of protein-protein interactions

  • X-ray crystallography or cryo-EM of COASY with its binding partners

These approaches collectively provide comprehensive characterization of COASY's interactome, which is particularly relevant given its involvement in multiple cellular pathways and disease mechanisms.

How can COASY expression analysis inform cancer therapeutics and personalized medicine approaches?

COASY expression analysis offers significant potential for cancer therapeutics and personalized medicine through several key approaches:

• Biomarker for radiation resistance:

  • COASY mRNA expression is consistently elevated in radioresistant human rectal cancers

  • Analysis of COASY levels in tumor biopsies could identify patients likely to be resistant to radiation therapy

  • This predictive capability could inform treatment decisions and stratify patients for alternative therapeutic approaches

• Therapeutic targeting strategies:

  • COASY knockdown sensitizes tumors to radiation, showing delayed growth, decreased proliferation, and increased apoptosis

  • Inhibiting the interaction between COASY and PI3K-P85α represents a potential therapeutic target

  • Combination therapy approaches coupling COASY inhibition with standard radiation protocols could improve outcomes in resistant tumors

• Methodological considerations for clinical implementation:

  • IHC with validated COASY antibodies (such as Abcam Cat# ab227272 at 1:500 dilution) on paraffin-embedded tissue sections provides a clinically applicable approach

  • qRT-PCR analysis of COASY mRNA from tumor biopsies offers quantitative assessment of expression levels

  • Development of standardized scoring systems for COASY expression would facilitate clinical interpretation

• Integration with existing molecular profiling:

  • COASY expression should be assessed alongside established biomarkers

  • Correlation with PI3K/AKT/mTOR pathway activation status provides additional predictive value

  • Multi-biomarker panels incorporating COASY may offer superior predictive capabilities

These approaches highlight COASY's potential as both a predictive biomarker and therapeutic target in cancer management, particularly for addressing radiation resistance in rectal cancers.

What are the methodological approaches for studying COASY in neurological disorders?

Investigation of COASY in neurological disorders requires specialized methodological approaches that address the unique challenges of neurological research:

• Genetic analysis approach:

  • Sequencing of COASY in patients with neurological symptoms, particularly those resembling classical CoPAN (COASY Protein-Associated Neurodegeneration)

  • Identification and classification of novel variants according to established reference sequences (e.g., NM_025233.7)

  • Family segregation analysis to confirm pathogenicity of identified variants

• Clinical phenotyping considerations:

  • Beyond classical CoPAN features, researchers should assess for atypical symptoms like deafness, language disorders, autism spectrum disorders, brain atrophy, and microcephaly

  • Special attention to epilepsy, which appears to be a frequent manifestation in COASY-related disorders

  • Comprehensive neurological and developmental assessments

• Transcriptomic and metabolic profiling:

  • Fibroblast transcriptomic analysis reveals dysregulation in genes associated with mitochondrial respiration, oxidative stress responses, and protein processing

  • Bioenergetic analysis showing impaired mitochondrial oxygen consumption provides functional confirmation

  • Assessment of mitochondrial 4′-phosphopantetheinylated proteins, which may be significantly reduced despite normal total CoA levels

• Neuroimaging approaches:

  • MRI analysis for brain atrophy, iron accumulation, and other structural abnormalities

  • Correlation of imaging findings with genetic variants and clinical manifestations

  • Longitudinal imaging to track disease progression

• Therapeutic investigation considerations:

  • Development of targeted approaches based on pathway dysfunction

  • Monitoring biomarkers of COASY function during therapeutic trials

  • Patient stratification based on specific genetic variants and phenotypes

These methodological approaches enable comprehensive investigation of COASY's role in neurological disorders, facilitating both improved diagnosis and potential therapeutic development.

What are the common technical challenges in COASY antibody applications and how can they be addressed?

Researchers frequently encounter several technical challenges when working with COASY antibodies, which can be systematically addressed:

• Non-specific binding in Western blot applications:

  • Challenge: Background bands or multiple bands appearing at unexpected molecular weights

  • Solution: Optimize blocking conditions (5% BSA often performs better than milk for phosphoprotein detection); increase washing stringency; titrate primary antibody from 1:500 to 1:3000 ; consider adding 0.1% Tween-20 to antibody dilution

• Weak signal in immunohistochemistry:

  • Challenge: Insufficient COASY detection in tissue sections

  • Solution: Optimize antigen retrieval method (try both TE buffer pH 9.0 and citrate buffer pH 6.0) ; use higher concentration of antibody (1:20-1:100 range) ; extend primary antibody incubation time; employ signal amplification systems

• Variable results in immunoprecipitation:

  • Challenge: Inconsistent pull-down efficiency

  • Solution: Adjust antibody amount (0.5-4.0 μg for 1.0-3.0 mg of total protein lysate) ; pre-clear lysates thoroughly; optimize lysis buffer conditions; ensure protein of interest is not masked by detergent effects

• Suboptimal immunofluorescence staining:

  • Challenge: Poor signal-to-noise ratio or non-specific staining

  • Solution: Titrate antibody concentration (1:50-1:500) ; optimize fixation method (try -20°C ethanol fixation as demonstrated successful) ; increase washing steps; use appropriate negative controls

• Sample-dependent variability:

  • Challenge: Inconsistent results across different sample types

  • Solution: The antibody should be titrated in each testing system to obtain optimal results ; validate antibody performance in each new sample type; include appropriate positive controls (HeLa cells for WB, IF/ICC; human colon cancer tissue for IHC)

These troubleshooting approaches ensure reliable and reproducible results when working with COASY antibodies across different experimental applications.

How can researchers validate COASY antibody specificity for their particular experimental system?

Thorough validation of COASY antibody specificity is essential for generating reliable experimental data. Researchers should employ multiple complementary approaches:

• Genetic manipulation controls:

  • Use COASY knockdown models (shRNA or CRISPR) to confirm signal reduction with antibody

  • Employ COASY overexpression systems to demonstrate increased signal

  • These genetic controls provide the strongest validation of antibody specificity

• Multi-technique concordance:

  • Confirm COASY detection across different methods (WB, IHC, IF) using the same antibody

  • Consistent detection of the 62 kDa band in Western blot corresponds with proper immunostaining in IHC/IF

  • Discrepancies between techniques may indicate context-dependent specificity issues

• Multiple antibody validation:

  • Test different antibodies targeting distinct COASY epitopes (e.g., Proteintech 12991-1-AP, Thermofisher PA528696, Abcam ab227272)

  • Concordant results with different antibodies strongly support specificity

  • Particularly important for novel findings or when studying previously uncharacterized tissues/cells

• Recombinant protein controls:

  • Use purified COASY protein as positive control

  • Pre-absorption controls with immunizing peptide should abolish specific signal

  • Particularly valuable for antibodies raised against recombinant fusion proteins

• Mass spectrometry confirmation:

  • Immunoprecipitation followed by mass spectrometry analysis confirms capture of genuine COASY protein

  • Particularly valuable for novel interaction studies or when working in complex tissue samples

These validation approaches ensure that experimental observations genuinely reflect COASY biology rather than antibody artifacts or cross-reactivity.

How might COASY research intersect with current trends in metabolic reprogramming and cancer therapy resistance?

The study of COASY represents a promising intersection with emerging research in metabolic reprogramming and therapy resistance mechanisms:

• Metabolic vulnerabilities in cancer:

  • COASY's critical role in CoA biosynthesis positions it as a potential metabolic vulnerability in cancer cells

  • Cancer cells with elevated COASY expression may depend on enhanced CoA biosynthesis for survival and proliferation

  • This metabolic dependency could be exploited therapeutically, particularly in combination with radiation therapy

• Integration with PI3K/AKT/mTOR signaling:

  • COASY's direct interaction with PI3K-P85α and subsequent activation of AKT/mTOR phosphorylation reveals a novel connection between metabolism and survival signaling

  • This interaction provides mechanistic insight into how metabolic enzymes can directly influence signaling pathways

  • Researchers should investigate whether COASY status affects sensitivity to PI3K/AKT/mTOR inhibitors in clinical use

• Methodological approaches for studying metabolic-signaling crosstalk:

  • Combined metabolomic and phosphoproteomic analyses

  • Real-time assessment of metabolic flux in COASY-manipulated cells

  • Investigation of how radiation exposure alters COASY-dependent metabolism

  • Systems biology approaches integrating multiple omics data types

• Therapeutic resistance mechanisms:

  • Beyond radiation resistance in rectal cancer , researchers should investigate COASY's potential role in resistance to other therapies

  • The COASY-PI3K-AKT axis may contribute to resistance to targeted therapies or immunotherapies

  • Combination approaches targeting both COASY and downstream signaling might overcome resistance mechanisms

These emerging research directions highlight COASY's potential significance beyond its canonical enzymatic function, positioning it at the interface of metabolism and signaling in cancer biology and therapy resistance.

What advanced methodologies are being developed to study the impact of COASY on mitochondrial function?

Cutting-edge methodological approaches are emerging to elucidate COASY's impact on mitochondrial function:

• High-resolution respirometry techniques:

  • Bioenergetic analysis has revealed impaired mitochondrial oxygen consumption in COASY-affected cells

  • Seahorse XF analyzers provide real-time measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR)

  • Substrate-specific respiratory protocols can pinpoint which aspects of the electron transport chain are compromised by COASY dysfunction

• Mitochondrial proteomics and protein modification analysis:

  • Despite comparable total CoA levels, mitochondrial 4′-phosphopantetheinylated proteins show significant reduction in COASY patients

  • Mass spectrometry-based approaches identify specific proteins affected by altered COASY function

  • Enrichment methods for pantetheinylated proteins allow comprehensive assessment of this post-translational modification

• Live-cell imaging of mitochondrial dynamics:

  • Fluorescent biosensors for CoA and its derivatives enable real-time monitoring in living cells

  • Analysis of mitochondrial morphology, fusion/fission dynamics, and quality control in COASY-manipulated cells

  • Correlative light and electron microscopy for ultrastructural analysis of mitochondria

• Single-cell transcriptomics and metabolomics:

  • Heterogeneity in mitochondrial responses to COASY manipulation can be assessed

  • Trajectory analysis reveals temporal dynamics of mitochondrial adaptation

  • Integration with spatial transcriptomics for tissue context

• CRISPR-based genetic screens:

  • Identification of synthetic lethal interactions with COASY deficiency

  • Screens for genetic modifiers that rescue mitochondrial dysfunction in COASY-deficient cells

  • Base editing approaches for precise modeling of patient-specific COASY variants

These advanced methodologies collectively provide unprecedented insights into how COASY impacts mitochondrial function, particularly relevant for understanding COASY-associated neurological disorders and potential therapeutic interventions.